به جمع مشترکان مگیران بپیوندید!

تنها با پرداخت 70 هزارتومان حق اشتراک سالانه به متن مقالات دسترسی داشته باشید و 100 مقاله را بدون هزینه دیگری دریافت کنید.

برای پرداخت حق اشتراک اگر عضو هستید وارد شوید در غیر این صورت حساب کاربری جدید ایجاد کنید

عضویت

جستجوی مقالات مرتبط با کلیدواژه « zinc sulphate » در نشریات گروه « پزشکی »

  • Behrouz Barati, Mahboobe Asadi, Ali Goljanian Tabrizi, Reza Karimi
    Background

    Exposure to excessive sound leads to hearing loss. Temporary threshold shifts are defined as threshold shifts that return to baseline levels in the hours to weeks after excessive sound exposure.

    Aim

    This study aimed to examine the zinc sulfate protective effect following noise exposure.

    Methods

    Fifty-two participants with normal audiograms at baseline were randomly assigned to control and intervention groups. First, a distortion product otoacoustic emission test (DPOAEs) was carried out as the baseline assessment, then the intervention group received zinc sulfate supplement capsules for one month and placebo capsules were given to controls. To induce a transient hearing shift, an ABR test was performed. The ABR test was done with 90 dB of soundstimuli for each ear. This input stimulus was a noise exposure that induces a temporary reduction in hearing, in fact, a transient hearing shift has occurred. Then, both groups had a DPOAE test anda follow-up assessment. Signal/noise ratio and DP (distortion product) levels were measured to evaluate the effect of zinc supplement use on transient hearing shift.

    Results

    Comparing the results of the distortion product otoacoustic emission test before and after the auditory brainstem response testing showed significant differences between intervention and control groups (p<0.05). Moreover, the differences in signal/noise ratio between the intervention group before and after ABR testing and also in the control group were significant (p<0.05).

    Conclusion

    Dailyzinc sulfate supplement might protect against thetransient hearing shift.

    Keywords: Zinc sulphate, Otoaucousticemission, Auditory brainstem response}
  • Soheila Nikakhlagh, Sara Saki, Morteza Saki, Majid Karimi
    Purpose
    The aim of this study is to find out the prevalence of hypozincemia in patients suffering from Tinnitusand to investigate the effect of Zinc therapy upon the severity of Tinnitus. Patients and
    Methods
    We studied 66 who suffered from tinnitus, which were randomized to two groups according to the zinc level including < 50 μg /dl and > 50 μg /dl groups. The zinc level was measured in non-diluted serum by flame atomic absorption spectrophotometry from fasting blood samples.
    Results
    The zinc level in< 50 μg /dl and > 50 μg /dl groups, before and after treatment (47.750 vs. 77.3 μg/dl, P < 0.02; 86.6 μg/dl vs. 98.2 50 μg /dl, P<0.001, respectively) was statistically significant. Hence, in Placebo group, before and after treatment the zinc level was not statistically significant (73.2 μg/dl vs.72.6 μg/dl, respectively).
    Conclusion
    The result showed that the mean of subjective tinnitus in zinc group decreased. However, the decrease in severity of the tinnitus was not significant in patients receiving placebo. The zinc level increased significantly in the patients treated with zinc.This study indicate that administration of zinc has a beneficial effect on tinnitus but these results still have to be confirmed in clinical trials with larger samples.
    Keywords: tinnitus, zinc sulphate, Atomic Absorption spectrophotometry}
  • Ali Fattahi Bafghi *, Mohammad Noorbala, Mohammad Taghi Noorbala, Mahdi Aghabagheri
    Background
    Cutaneous leishmaniasis (CL) is an endemic disease in developing countries. Although pentamidine orantimonite (Glucantime) has been recommended for cutaneous leishmaniasis treatment by the World Health Organization, there are some concerns too such as high cost, side effects, need for frequent injections, and restricted efficacy. Therefore, different methods have been used for CL treatment so far..
    Objectives
    This study assessed the sensitivity of two parasite agents of cutaneous leishmaniasis: Leishmania major and L. tropica to zinc sulphate in vitro. In the present study, the zinc sulphate effect on urban and rural strains of cutaneous leishmaniasis, viability of old world, in vitro is under investigation..
    Materials And Methods
    The design of the present study was experimental (laboratory-trial) based. Iranian endemic species of L. major and L. tropica were appropriately collected, proliferated, and maintained in the standard culture. Afterward, the proper concentrations of zinc sulphate were provided, sterilized, and added to the cultures containing parasites. In different intervals, parasites were counted by two
    Methods
    the slide and cell proliferation ELISA..
    Results
    Both parasite species showed sensitivity to zinc sulphate in vitro and in comparison with the control group, their numbers were reduced. Zinc sulphate (in concentrations of 0.5, 1, 2, and 3percent) was added to the cultures containing parasites, and the total number of the live parasites was counted through the slide method (Neubauer slide) every day up to the fifth day. The results were analyzed and found statistically significant (P < 0.05). In the second phase, the counting process was repeated with the addition of zinc sulphate compound with different concentrations (3, 4, 5, and 6 percent) and live parasite numbers were counted by ELISA method after 24 hours. The findings revealed that all the cultures containing zinc sulphate showed a slower growth in comparison to the control group. The mentioned difference was statistically significant (P < 0.05)...
    Conclusions
    Considering the safety of zinc sulphate compound in comparison with Glucantime, there is a possibility of using it in the treatment of CL caused by both species of L. major and L. tropica. It is obvious that more researches are mandatory both in vivo and in vitro to figure out its daily dosage, proper concentration, time and duration, and possible side effects..
    Keywords: Cutaneous Leishmaniasis, Zinc Sulphate, In Vitro, Therapeutics}
  • فاطمه اربابی کلاتی، فرشید اربابی کلاتی
    زمینه
    سرکوب مغز استخوان از عوارض تهدیدکننده حیات، ناشی از شیمی درمانی است که متعاقب ایجاد نوتروپنی یا لکوپنی، موجب نیاز به بستری یا استفاده از آنتی بیوتیک ها در بیماران می گردد. در چندین بررسی از مکمل روی در کنار شیمی درمانی برای کاهش عوارض درمان سرطان استفاده شده و نتایج نشان دهنده کاهش عود موضعی و متاستاز و افزایش میزان بقا بوده است. بنابراین پژوهش کنونی جهت بررسی اثر سولفات روی خوراکی در پیشگیری از تغییرات خونی ناشی از شیمی درمانی طراحی شده است.
    مواد و روش ها
    این تحقیق یک کارآزمایی بالینی دوسوکور بود، که 50 بیمار بزرگسال تحت شیمی درمانی در طی سال های 88-87 وارد مطالعه شدند. بیماران به صورت تصادفی به دو گروه 25 تایی سولفات روی یا دارونما تقسیم شدند. بیماران گروه مورد همزمان با شروع شیمی درمانی روزانه 3 عدد کپسول سولفات روی 220 میلی گرمی (ساخت شرکت الحاوی) را تا پایان دوره شیمی درمانی دریافت می کردند. گروه کنترل نیز همزمان با شروع شیمی درمانی روزانه 3 عدد کپسول حاوی دارونما که از لحاظ شکل، طعم و رنگ مشابه دارو بود و توسط شرکت سازنده داروی سولفات روی تهیه شده بود را تا پایان دوره شیمی درمانی دریافت کردند. داده ها با استفاده از نرم افزار SPSS ویرایش 17 و آزمون تی مستقل مورد بررسی قرار گرفت.
    یافته ها
    در این مطالعه بین دو گروه مورد و شاهد از نظر تعداد گلبول های سفید (7/0=P value)، گلبول های قرمز (4/0=P value) و میزان هموگلوبین (9/0=P value) پس از مداخله تفاوت آماری معنی داری مشاهده نشد (CI= 95 درصد).
    نتیجه گیری
    بر اساس نتایج این مطالعه استفاده از سولفات روی خوراکی نمی تواند از تغییرات خونی ناشی از شیمی درمانی جلوگیری کند.
    کلید واژگان: سولفات روی, شیمی درمانی, تغییرات خونی, گلبول های سفید}
    Fatemeh Arbabi, Kalati, Farshid Arbabi, Kalati
    Background
    Bone marrow suppression as a serious complication of chemotherapy induces leucopenia or neutropenia that results to hospitalization and antibiotic therapy. Several studies used zinc supplement for reduction of chemotherapy side effects’، these studies showed that zinc can prevent metastasis، local recurrence and increases survival rate، so this study conducted to evaluate preventive effect of oral zinc sulphate on hematologic changes induced by chemotherapy.
    Material And Methods
    This double blind randomized controlled trial enrolled 50 adult patients who were under chemotherapy during 2008-2009. Subjects were randomly divided into two groups. By the beginning of chemotherapy، the patients in each group received three 220 mg zinc sulphate capsules daily (Alhavi Co.) or placebo capsules provided by zinc sulphate manufacturing company، which were similar in shape، taste and color to zinc sulphate capsules. This diet followed up to end of study. Then data was analyzed by SPSS17 software using independent sample T-test.
    Results
    There was no statistically significance between white blood cell count (p=0. 7)، red blood cells count (p=0. 4) and hemoglobin (p=0. 9) in zinc sulphate and placebo groups (CI=95%).
    Conclusion
    It can be concluded that zinc sulphate cannot prevent hematologic changes induced by chemotherapy.
    Keywords: zinc sulphate, chemotherapy, hematologic changes, white blood cells}
نکته
  • نتایج بر اساس تاریخ انتشار مرتب شده‌اند.
  • کلیدواژه مورد نظر شما تنها در فیلد کلیدواژگان مقالات جستجو شده‌است. به منظور حذف نتایج غیر مرتبط، جستجو تنها در مقالات مجلاتی انجام شده که با مجله ماخذ هم موضوع هستند.
  • در صورتی که می‌خواهید جستجو را در همه موضوعات و با شرایط دیگر تکرار کنید به صفحه جستجوی پیشرفته مجلات مراجعه کنید.
درخواست پشتیبانی - گزارش اشکال